Current Environment: Production

Deborah R. Stein | Education

Undergraduate School

Tufts University

2000, Boston, MA

Medical School

Tufts University School of Medicine

2005, Boston, MA

Internship

Floating Hospital for Children Tufts Medical Center

2006, Boston, MA

Residency

Floating Hospital for Children Tufts Medical Center

2008, Boston, MA

Fellowship

Pediatric Nephrology

Boston Children's Hospital

2011, Boston, MA

Deborah R. Stein | Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Nephrology)

Deborah R. Stein | Professional History

Dr. Deborah Stein grew up in the Boston area, where she completed high school and attended Tufts University, where she was a member of the swim team. After obtaining a degree in chemistry and working in industry, she returned to Tufts University School of Medicine where she completed medical school. She continued at Floating Hospital for Children for residency and then Boston Children’s Hospital for training in Pediatric Nephrology. She is board-certified in Pediatrics and Pediatric Nephrology, and has been a member of the faculty since 2011 when she completed her training.

Dr. Stein is an active member of the American Society of Pediatric Nephrology as well as multiple other professional societies. She has worked with Open Pediatrics to develop online simulators to teach medical professionals about dialysis in children, which won the 2016 American Society of Nephrology Innovations in Kidney Education Award. She was named to the Boston Combined Residency Program Faculty Teaching Honor Roll for the 2017-2018 academic year.

Deborah R. Stein | Media

Caregiver Profile

Meet Dr. Deborah Stein

Deborah R. Stein | Publications

  1. Trio exome sequencing in individuals with CAKUT identifies de novo variants in potential novel candidate genes in 19.62. Genet Med. 2025 Apr 10; 101432. View Trio exome sequencing in individuals with CAKUT identifies de novo variants in potential novel candidate genes in 19.62. Abstract

  2. Beyond Childhood: The Lifelong Kidney Risks for Children with Posterior Urethral Valves. J Am Soc Nephrol. 2024 Dec 01; 35(12):1633-1635. View Beyond Childhood: The Lifelong Kidney Risks for Children with Posterior Urethral Valves. Abstract

  3. Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives. Pediatr Nephrol. 2024 Oct; 39(10):2845-2860. View Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives. Abstract

  4. Congenital Anomalies of the Kidneys and Urinary Tract. Clin Perinatol. 2022 09; 49(3):791-798. View Congenital Anomalies of the Kidneys and Urinary Tract. Abstract

  5. Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT. Genet Med. 2022 02; 24(2):307-318. View Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT. Abstract

  6. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2021 09; 155:216-226. View Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Abstract

  7. Surgical management of pediatric renovascular hypertension and midaortic syndrome at a single-center multidisciplinary program. J Vasc Surg. 2021 07; 74(1):79-89.e2. View Surgical management of pediatric renovascular hypertension and midaortic syndrome at a single-center multidisciplinary program. Abstract

  8. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742. View Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Abstract

  9. Phenotype expansion of heterozygous FOXC1 pathogenic variants toward involvement of congenital anomalies of the kidneys and urinary tract (CAKUT). Genet Med. 2020 10; 22(10):1673-1681. View Phenotype expansion of heterozygous FOXC1 pathogenic variants toward involvement of congenital anomalies of the kidneys and urinary tract (CAKUT). Abstract

  10. Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease. Kidney Int Rep. 2020 Aug; 5(8):1316-1319. View Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease. Abstract

  11. Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 May; 50(5):755-756. View Correction to: Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Abstract

  12. Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Pediatr Radiol. 2020 05; 50(5):698-705. View Prospective pediatric study comparing glomerular filtration rate estimates based on motion-robust dynamic contrast-enhanced magnetic resonance imaging and serum creatinine (eGFR) to 99mTc DTPA. Abstract

  13. Renal outcomes of neonates with early presentation of posterior urethral valves: a 10-year single center experience. J Perinatol. 2020 01; 40(1):112-117. View Renal outcomes of neonates with early presentation of posterior urethral valves: a 10-year single center experience. Abstract

  14. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. J Am Soc Nephrol. 2019 02; 30(2):201-215. View Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. Abstract

  15. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol. 2018 09; 29(9):2348-2361. View Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. Abstract

  16. Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Ann Surg. 2018 06; 267(6):e109-e111. View Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Abstract

  17. Teaching Pediatric Peritoneal Dialysis Globally through Virtual Simulation. Clin J Am Soc Nephrol. 2018 06 07; 13(6):900-906. View Teaching Pediatric Peritoneal Dialysis Globally through Virtual Simulation. Abstract

  18. Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox. J Pediatr. 2018 07; 198:313-316. View Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox. Abstract

  19. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 04; 71(4):691-699. View Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Abstract

  20. Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. J Vasc Surg. 2018 06; 67(6):1664-1672. View Tissue expander-stimulated lengthening of arteries for the treatment of midaortic syndrome in children. Abstract

  21. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 01 06; 13(1):53-62. View Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Abstract

  22. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Abstract

  23. Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatr Nephrol. 2018 02; 33(2):305-314. View Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Abstract

  24. Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control. 2016; 9:49-58. View Evaluation and treatment of hypertensive crises in children. Abstract

  25. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014 Dec; 10(6):982-98. View Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). Abstract

  26. Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Pediatr Nephrol. 2013 Oct; 28(10):2023-33. View Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management. Abstract

  27. Vitamin D status in children with chronic kidney disease. Pediatr Nephrol. 2012 Aug; 27(8):1341-50. View Vitamin D status in children with chronic kidney disease. Abstract

  28. Enhancing vapor sensor discrimination by mimicking a canine nasal cavity flow environment. J Am Chem Soc. 2003 Apr 02; 125(13):3684-5. View Enhancing vapor sensor discrimination by mimicking a canine nasal cavity flow environment. Abstract

I entered medical school with many interests, but my degree in chemistry and prior work as a chemist made nephrology a natural fit. I enjoy providing both acute and chronic care for patients with renal conditions

BESbswy
BESbswy